Sirturo (bedaquiline fumarate) — Medica
Pulmonary tuberculosis due to Mycobacterium tuberculosis resistant to at least rifampin and isoniazid
Initial criteria
- Patient is age ≥ 2 years
- Patient weighs ≥ 8 kg
- Patient has Mycobacterium tuberculosis resistant to rifampin and isoniazid
- Sirturo is prescribed as part of a combination regimen with other anti-tuberculosis agents
- Medication is prescribed by or in consultation with an infectious diseases specialist
Approval duration
6 months